Miravant Medical Technologies logo

MRVT - Miravant Medical Technologies Share Price

$0 0.0  0.0%

Last Trade - 03/06/20

Sector
Healthcare
Size
Micro Cap
Market Cap £9.05k
Enterprise Value £10.4m
Revenue £n/a
Position in Universe th / 6327
Bullish
Bearish
Unlock MRVT Revenue
Momentum
Relative Strength (%)
1m +28,609%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 1999 2000 2001 2002 2003 2004 2005E 2006E CAGR / Avg
14.6 4.59 4.68 0.50 0.000 0.000 -100.0%
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2005, Miravant Medical Technologies revenues was not reported. Net loss decreased 4% to $12.1M. Lower net loss reflects Interest Expense decrease of 40% to $1.5M (expense), Other increase from $80K to $171K (income). Basic Earnings per Share excluding Extraordinary Items increased from -$0.40 to -$0.32.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

MRVT Revenue Unlock MRVT Revenue

Net Income

MRVT Net Income Unlock MRVT Revenue

Normalised EPS

MRVT Normalised EPS Unlock MRVT Revenue

PE Ratio Range

MRVT PE Ratio Range Unlock MRVT Revenue

Dividend Yield Range

MRVT Dividend Yield Range Unlock MRVT Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
MRVT EPS Forecasts Unlock MRVT Revenue
Profile Summary

Miravant Medical Technologies is a pharmaceutical research and development company engaged in photodynamic therapy (PDT), a treatment modality based on drugs that respond to light. The drug and light procedures involve three components, the photoselective drugs, light producing devices and light delivery devices. The Company's products have been developed in-house and with outside collaborators and have been used in various clinical and preclinical investigations. Its most advanced drug, PHOTREX, generic name rostaporfin, has completed two Phase III clinical trials for the treatment of wet age-related macular degeneration (AMD). Miravant has branded its version of PDT technology with the trademark PhotoPoint.

Directors
Last Annual December 31st, 2004
Last Interim September 30th, 2005
Incorporated June 16, 1989
Public Since December 20, 1995
No. of Shareholders: 6,000
No. of Employees: 47
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 46,969,934
Free Float (0.0%)
Eligible for
ISAs
SIPPs
MRVT Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for MRVT
Upcoming Events for MRVT
Frequently Asked Questions for Miravant Medical Technologies
What is the Miravant Medical Technologies share price?

As of 03/06/20, shares in Miravant Medical Technologies are trading at $0, giving the company a market capitalisation of £9.05k. This share price information is delayed by 15 minutes.

How has the Miravant Medical Technologies share price performed this year?

Shares in Miravant Medical Technologies are currently trading at $0 and the price has moved by 2.90k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Miravant Medical Technologies price has moved by 2.87k% over the past year.

What are the analyst and broker recommendations for Miravant Medical Technologies?

There are no analysts currently covering Miravant Medical Technologies.

When will Miravant Medical Technologies next release its financial results?

Miravant Medical Technologies is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2006-09-30
What is the Miravant Medical Technologies dividend yield?

Miravant Medical Technologies does not currently pay a dividend.

Does Miravant Medical Technologies pay a dividend?

Miravant Medical Technologies does not currently pay a dividend.

When does Miravant Medical Technologies next pay dividends?

Miravant Medical Technologies does not currently pay a dividend.

How do I buy Miravant Medical Technologies shares?

To buy shares in Miravant Medical Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Miravant Medical Technologies?

Shares in Miravant Medical Technologies are currently trading at $0, giving the company a market capitalisation of £9.05k.

Where are Miravant Medical Technologies shares listed? Where are Miravant Medical Technologies shares listed?

Here are the trading details for Miravant Medical Technologies:

Country of listing: United States
Exchange: PNK
Ticker Symbol: MRVT
What kind of share is Miravant Medical Technologies?

We were not able to load our ranking data for Miravant Medical Technologies

Is there a Miravant Medical Technologies share price forecast 2020?

We were not able to load any forecast data for Miravant Medical Technologies.

How can I tell whether the Miravant Medical Technologies share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Miravant Medical Technologies. Over the past six months, the relative strength of its shares against the market has been 32.1k%. At the current price of $0, shares in Miravant Medical Technologies are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Miravant Medical Technologies PE Ratio?

We were not able to find PE ratio data for Miravant Medical Technologies.

Who are the key directors of Miravant Medical Technologies?

Miravant Medical Technologies's management team is headed by:

David Mai - DRC
John Philpott - ASC
Robert Sutcliffe - NEC
Michael Khoury - DRC
Nuno Brandolini - DRC
Kevin McCarthy - DRC
Who are the major shareholders of Miravant Medical Technologies?

Here are the top five shareholders of Miravant Medical Technologies based on the size of their shareholding:

Similar to MRVT
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.